BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 18437259)

  • 1. Cost-effectiveness of continuous positive airway pressure therapy in patients with obstructive sleep apnea-hypopnea in British Columbia.
    Tan MC; Ayas NT; Mulgrew A; Cortes L; FitzGerald JM; Fleetham JA; Schulzer M; Ryan CF; Ghaeli R; Cooper P; Marra CA
    Can Respir J; 2008 Apr; 15(3):159-65. PubMed ID: 18437259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of continuous positive airway pressure therapy for moderate to severe obstructive sleep apnea/hypopnea.
    Ayas NT; FitzGerald JM; Fleetham JA; White DP; Schulzer M; Ryan CF; Ghaeli R; Mercer GW; Cooper P; Tan MC; Marra CA
    Arch Intern Med; 2006 May; 166(9):977-84. PubMed ID: 16682570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical effectiveness and cost-effectiveness results from the randomised controlled Trial of Oral Mandibular Advancement Devices for Obstructive sleep apnoea-hypopnoea (TOMADO) and long-term economic analysis of oral devices and continuous positive airway pressure.
    Sharples L; Glover M; Clutterbuck-James A; Bennett M; Jordan J; Chadwick R; Pittman M; East C; Cameron M; Davies M; Oscroft N; Smith I; Morrell M; Fox-Rushby J; Quinnell T
    Health Technol Assess; 2014 Oct; 18(67):1-296. PubMed ID: 25359435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COST-EFFECTIVENESS OF TREATMENTS FOR MILD-TO-MODERATE OBSTRUCTIVE SLEEP APNEA IN FRANCE.
    Poullié AI; Cognet M; Gauthier A; Clementz M; Druais S; Späth HM; Perrier L; Scemama O; Pichon CR; Harousseau JL
    Int J Technol Assess Health Care; 2016 Jan; 32(1-2):37-45. PubMed ID: 26956455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An integrated health-economic analysis of diagnostic and therapeutic strategies in the treatment of moderate-to-severe obstructive sleep apnea.
    Pietzsch JB; Garner A; Cipriano LE; Linehan JH
    Sleep; 2011 Jun; 34(6):695-709. PubMed ID: 21629357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of Continuous Positive Airway Pressure Treatment in Moderate-Severe Obstructive Sleep Apnea Syndrome.
    Català R; Villoro R; Merino M; Sangenís S; Colomés L; Hernández Flix S; Pérez de Llano LA
    Arch Bronconeumol; 2016 Sep; 52(9):461-9. PubMed ID: 26993090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical- and Cost-Effectiveness of a Mandibular Advancement Device Versus Continuous Positive Airway Pressure in Moderate Obstructive Sleep Apnea.
    de Vries GE; Hoekema A; Vermeulen KM; Claessen JQPJ; Jacobs W; van der Maten J; van der Hoeven JH; Stegenga B; Kerstjens HAM; Wijkstra PJ
    J Clin Sleep Med; 2019 Oct; 15(10):1477-1485. PubMed ID: 31596213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous positive airway pressure devices for the treatment of obstructive sleep apnoea-hypopnoea syndrome: a systematic review and economic analysis.
    McDaid C; Griffin S; Weatherly H; Durée K; van der Burgt M; van Hout S; Akers J; Davies RJ; Sculpher M; Westwood M
    Health Technol Assess; 2009 Jan; 13(4):iii-iv, xi-xiv, 1-119, 143-274. PubMed ID: 19103134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-utility and budget impact analysis of CPAP therapy compared to no treatment in the management of moderate to severe obstructive sleep apnea in Colombia from a third-party payer perspective.
    Robles A; Gil-Rojas Y; Amaya D; Hernández F; Escobar-Cordoba F; Venegas M; Amado S; Restrepo-Gualteros S; Echeverry J; Marín F; Zabala S; Bazurto-Zapata MA; Deger M
    Expert Rev Pharmacoecon Outcomes Res; 2023 Apr; 23(4):399-407. PubMed ID: 36852713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An economic analysis of continuous positive airway pressure for the treatment of obstructive sleep apnea-hypopnea syndrome.
    Weatherly HL; Griffin SC; Mc Daid C; Durée KH; Davies RJ; Stradling JR; Westwood ME; Sculpher MJ
    Int J Technol Assess Health Care; 2009 Jan; 25(1):26-34. PubMed ID: 19126248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of continuous positive airway pressure therapy for obstructive sleep apnea: health care system and societal perspectives.
    Streatfeild J; Hillman D; Adams R; Mitchell S; Pezzullo L
    Sleep; 2019 Dec; 42(12):. PubMed ID: 31403163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of oral appliances in the treatment of obstructive sleep apnoea-hypopnoea.
    Sadatsafavi M; Marra CA; Ayas NT; Stradling J; Fleetham J
    Sleep Breath; 2009 Aug; 13(3):241-52. PubMed ID: 19229577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic evaluation of CPAP therapy for obstructive sleep apnea: a scoping review and evidence map.
    Pachito DV; Bagattini ÂM; Drager LF; Eckeli AL; Rocha A
    Sleep Breath; 2022 Mar; 26(1):17-30. PubMed ID: 33788132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of using continuous positive airway pressure in the treatment of severe obstructive sleep apnoea/hypopnoea syndrome in the UK.
    Guest JF; Helter MT; Morga A; Stradling JR
    Thorax; 2008 Oct; 63(10):860-5. PubMed ID: 18408048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk and severity of motor vehicle crashes in patients with obstructive sleep apnoea/hypopnoea.
    Mulgrew AT; Nasvadi G; Butt A; Cheema R; Fox N; Fleetham JA; Ryan CF; Cooper P; Ayas NT
    Thorax; 2008 Jun; 63(6):536-41. PubMed ID: 18234904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-Term Cost-Effectiveness of Upper Airway Stimulation for the Treatment of Obstructive Sleep Apnea: A Model-Based Projection Based on the STAR Trial.
    Pietzsch JB; Liu S; Garner AM; Kezirian EJ; Strollo PJ
    Sleep; 2015 May; 38(5):735-44. PubMed ID: 25348126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring the Potential Cost-Effectiveness of Patient Decision Aids for Use in Adults with Obstructive Sleep Apnea: A Case Study.
    Trenaman L; Sadatsafavi M; Almeida F; Ayas N; Lynd L; Marra C; Stacey D; Bansback N
    Med Decis Making; 2015 Jul; 35(5):671-82. PubMed ID: 25344130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A health-economic analysis of diagnosis and treatment of obstructive sleep apnea with continuous positive airway pressure in relation to cardiovascular disease. The Greek experience.
    Trakada G; Economou NT; Nena E; Trakada A; Zarogoulidis P; Steiropoulos P
    Sleep Breath; 2015 May; 19(2):467-72. PubMed ID: 25138389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral appliances for obstructive sleep apnoea.
    Lim J; Lasserson TJ; Fleetham J; Wright J
    Cochrane Database Syst Rev; 2006 Jan; 2006(1):CD004435. PubMed ID: 16437488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcomes and cost-effectiveness of continuous positive airway pressure to manage obstructive sleep apnea in patients with type 2 diabetes in the U.K.
    Guest JF; Panca M; Sladkevicius E; Taheri S; Stradling J
    Diabetes Care; 2014; 37(5):1263-71. PubMed ID: 24705611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.